WARDWIZARD [WARDHEALTH] vs Motilal Oswal [MOTILALOFS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: WARDWIZARD HEALTHCARE LIMITED wins in 5 metrics, Motilal Oswal Financial Services Ltd. wins in 13 metrics, with 0 ties. Motilal Oswal Financial Services Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric WARDWIZARD HEALTHCARE LIMITED Motilal Oswal Financial Services Ltd. Better
P/E Ratio (TTM) -0.41 24.07 Motilal Oswal Financial Services Ltd.
Price-to-Book Ratio -0.31 3.69 Motilal Oswal Financial Services Ltd.
Debt-to-Equity Ratio -0.85 121.04 Motilal Oswal Financial Services Ltd.
PEG Ratio 0.01 -0.48 WARDWIZARD HEALTHCARE LIMITED
EV/EBITDA -2.32 17.21 Motilal Oswal Financial Services Ltd.
Profit Margin (TTM) -191.01% 30.54% Motilal Oswal Financial Services Ltd.
Operating Margin (TTM) -104.61% 41.85% Motilal Oswal Financial Services Ltd.
EBITDA Margin (TTM) N/A 41.85% N/A
Return on Equity 87.16% 22.47% WARDWIZARD HEALTHCARE LIMITED
Return on Assets (TTM) -31.04% 7.36% Motilal Oswal Financial Services Ltd.
Free Cash Flow (TTM) $-16.42M $9.30B Motilal Oswal Financial Services Ltd.
Dividend Yield N/A 1.47% N/A
1-Year Return 107.32% -1.72% WARDWIZARD HEALTHCARE LIMITED
Price-to-Sales Ratio (TTM) 1.20 7.18 WARDWIZARD HEALTHCARE LIMITED
Enterprise Value $41.15M $565.94B Motilal Oswal Financial Services Ltd.
EV/Revenue Ratio 4.46 8.53 WARDWIZARD HEALTHCARE LIMITED
Gross Profit Margin (TTM) -66.28% 57.06% Motilal Oswal Financial Services Ltd.
Revenue per Share (TTM) $38 $111 Motilal Oswal Financial Services Ltd.
Earnings per Share (Diluted) $-71.88 $32.85 Motilal Oswal Financial Services Ltd.
Beta (Stock Volatility) 0.46 0.00 Motilal Oswal Financial Services Ltd.

WARDWIZARD HEALTHCARE LIMITED vs Motilal Oswal Financial Services Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
WARDWIZARD HEALTHCARE LIMITED0.00%0.00%0.00%0.00%4.98%0.00%
Motilal Oswal Financial Services Ltd.6.84%3.87%5.55%27.39%2.76%5.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
WARDWIZARD HEALTHCARE LIMITED107.32%151.89%151.89%151.89%151.89%151.89%
Motilal Oswal Financial Services Ltd.-1.72%27.90%6.02%153.40%750.25%338.78%

Performance & Financial Health Analysis: WARDWIZARD HEALTHCARE LIMITED vs Motilal Oswal Financial Services Ltd.

MetricWARDHEALTHMOTILALOFS
Market Information
Market Cap i₹11.11M₹470.64B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i501,383,064
90 Day Avg. Volume i171,162,668
Last Close₹45.34₹888.45
52 Week Range₹21.87 - ₹45.34₹614.90 - ₹1,097.10
% from 52W High0.00%-19.02%
All-Time High₹45.34 (Dec 22, 2025)₹1,588.40 (Jan 08, 2018)
% from All-Time High0.00%-44.07%
Growth Metrics
Quarterly Revenue Growth0.97%0.04%
Quarterly Earnings Growth-0.11%0.00%
Financial Health
Profit Margin (TTM) i-1.91%0.31%
Operating Margin (TTM) i-1.05%0.42%
Return on Equity (TTM) i0.87%0.22%
Debt to Equity (MRQ) i-0.85121.04
Cash & Liquidity
Book Value per Share (MRQ)₹-145.25₹214.51
Cash per Share (MRQ)₹0.55₹130.81
Operating Cash Flow (TTM) i₹-32,040,000₹3.24B
Levered Free Cash Flow (TTM) i₹-27,133,000₹25.02B
Dividends
Last 12-Month Dividend Yield iN/A1.47%
Last 12-Month Dividend iN/A₹11.00

Valuation & Enterprise Metrics Analysis: WARDWIZARD HEALTHCARE LIMITED vs Motilal Oswal Financial Services Ltd.

MetricWARDHEALTH (Apr 24, 2026)MOTILALOFS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-0.4124.07
Forward P/E iN/A15.40
PEG Ratio i0.01-0.48
Price to Sales (TTM) i1.207.18
Price to Book (MRQ) i-0.313.69
Market Capitalization
Market Capitalization i₹11.11M₹470.64B
Enterprise Value i₹41.15M₹565.94B
Enterprise Value Metrics
Enterprise to Revenue i4.468.53
Enterprise to EBITDA i-2.3217.21
Risk & Other Metrics
Beta i0.460.00
Book Value per Share (MRQ) i₹-145.25₹214.51

Financial Statements Comparison: WARDWIZARD HEALTHCARE LIMITED vs Motilal Oswal Financial Services Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricWARDHEALTH (2025)MOTILALOFS (2025)
Revenue/Sales i4.17M64.42B
Cost of Goods Sold i7.09M29.15B
COGS % of Revenue i170.1%45.3%
Gross Profit i-2.92M35.26B
Gross Margin i-70.1%54.7%
Research & Development iN/AN/A
Operating Income (EBIT) i-22.74M25.50B
Operating Margin i-545.3%39.6%
EBITDA i-17.79M32.88B
EBITDA Margin i-426.5%51.0%
Pre-Tax Income i-28.25M32.26B
Pre-Tax Income % of Revenue i-677.4%50.1%
Income Tax i-1.12M7.18B
Income Tax % of Revenue i-26.8%11.1%
Net Income (Profit) i-27.13M25.08B
Profit Margin i-650.6%38.9%

Balance Sheet & Liquidity Metrics

MetricWARDHEALTH (2025)MOTILALOFS (2025)
Cash & Equivalents i275,00065.93B
Total Current Assets i3.50M213.42B
Total Current Assets % of Revenue i83.8%331.3%
Total Current Liabilities i48.32M173.38B
Total Current Liabilities % of Revenue i1,158.7%269.2%
Long-Term Debt i69.75M45.29B
Long-Term Debt % of Revenue i1,672.8%70.3%
Total Shareholders Equity i-31.13M111.31B
Retained Earnings i-33.58M93.43B
Retained Earnings % of Revenue i-805.3%145.0%
Property, Plant & Equipment i72.78M6.96B

Cash Flow Statement Comparison

MetricWARDHEALTH (2025)MOTILALOFS (2025)
Operating Cash Flow i-32.04M3.24B
Operating Cash Flow % of Revenue i-768.3%5.0%
Capital Expenditures i-79,000-2.81B
Free Cash Flow i-16.42M9.30B
FCF Margin i-393.9%14.4%
Debt Repayment iN/A-7.60B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricWARDHEALTHMOTILALOFS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i245,000601.86M
Float Shares i14,306157.71M
% Held by Insiders i94.16%53.12%
% Held by Institutions i0.00%28.33%
% Held by Public i5.84%18.55%

Dividend Analysis & Yield Comparison: WARDWIZARD HEALTHCARE LIMITED vs Motilal Oswal Financial Services Ltd.

MetricWARDHEALTHMOTILALOFS
Last 12-Month Dividend iN/A₹11.00
Last 12-Month Dividend Yield iN/A1.47%
3-Year Avg Annual Dividend iN/A₹4.17
3-Year Avg Dividend Yield iN/A0.36%
3-Year Total Dividends iN/A₹12.51
Ex-Dividend DateN/AJan 30, 2026